Neutral
Principal Financial Group Inc. significantly increased its stake in Bio-Techne Corp by 316.7% in the fourth quarter of the prior fiscal year, holding ...
Neutral
Citigroup has lowered its price target for Bio-Techne (NASDAQ:TECH) from $80.00 to $70.00, though it maintained a "buy" rating, indicating a potential...
Neutral
Vanguard Group Inc. decreased its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 0.7% in the fourth quarter, according to the co...
Neutral
Comerica Bank raised its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 56.4% in the fourth quarter, HoldingsChannel reports. Th...
Bullish
Bio-Techne (NASDAQ:TECH) is slated to release its Q3 2026 financial results before market open on Wednesday, May 6th, with analysts projecting earning...